exp:news_feed:department site="cellbio" category_id="186" parse="inward" year="2018" month="" count=""

News & Articles : 2018

From left, Sandra Bacman, Ph.D., with Carlos T. Moraes, Ph.D.

Advances in Gene Editing and Delivery Offer Promise for People Living with Mitochondrial Diseases

There is strength in numbers — or at least the right proportion. A new study from University of Miami Miller School of Medicine researchers demonstrates an ability to target and reduce debilitating high levels of mutant mitochondrial DNA in heart and other muscle tissue to an extent — so far in mice — that could be curative. The findings offer hope to people living with relatively rare mitochondrial diseases.

Read more »

Feng Gong, Ph.D., enjoys the interactive aspects of teaching M.D. and M.D./MPH students and training residents.

Miller School Professors Recognized for Promoting Positive Learning Environment in PULSE 360 Survey

In all, 33 Miller School professors received high scores for promoting a positive learning environment in the first PULSE 360 Survey for Faculty-Learner Engagement. The survey was performed by the Physicians Development Program Inc., an independent organization, to allow comparison to national data and to assure anonymous feedback to individual faculty members.

Read more »

In an upcoming phase two human study, researchers will use nine outcome fields — cognitive, behavioral, psychosocial, sleep, pain, sensorimotor, cardiovascular, inflammatory biomarkers, and neuroimaging studies — to evaluate the drug’s efficacy.

‘Concussion Pill’ Shows Promise in Pre-Clinical Pilot Study

Researchers at the University of Miami Miller School of Medicine and The Miami Project to Cure Paralysis, along with their partners at Scythian Biosciences, are one step closer to finding a new treatment for concussion. In 2016, the multidisciplinary Miller School team embarked on a five-year study to examine the effects of combining CBD with an NMDA antagonist for the treatment of traumatic brain injury and concussion.

Read more »

Isaiah Hankel, Ph.D., founder of Cheeky Scientist, offered tips for transition to careers in industry.

Symposium for Graduate and Post-Doctoral Students Offers Valuable Information on Career Options

The University of Miami Career Development Committee, a Ph.D.-student-run branch under the Biomedical Graduate Student Government and the Office of Graduate and Postdoctoral Studies, hosted its first annual Graduate Student/Post-Doc Career Symposium on May 30. The goal of the symposium was to provide Ph.D. and post-doctoral students with a comprehensive workshop on career options and skill sets needed to obtain career goals.

Read more »

From left, Luis Chiappy, AXA Advisors, Mary Bartlett Bunge, Ph.D., and Chris Dudley, Advancement Associates, Inc.

UM Researcher, Transplant Surgeon and Sylvester Trustee among 2018 Health Care Heroes

For nearly 30 years, Mary Bartlett Bunge, Ph.D., worked tirelessly as a neuroscientist with The Miami Project to Cure Paralysis at the University of Miami Miller School of Medicine. Her pioneering work in the area of nervous system regeneration and her decades-long dedication to finding ways to repair spinal cord damage earned Bunge the 2018 Lifetime Achievement Award from the Greater Miami Chamber of Commerce.

Read more »

Illustration of T cells (blue/red) attacking cancer cells.

Researchers Develop New Therapeutic Approach to Helping Immune System Recognize Tumor Cells

Investigators at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine report a promising strategy that could help the immune system recognize tumor cells as different and dangerous, mount an immediate attack, and remove them as efficiently as it does with cells infected with threatening viruses or bacteria.

Read more »

From left, Ivonne Schulman, M.D., with Lina Shehadeh, Ph.D.

Miller School Researcher Receives $1.5 Million Grant to Study Role of Osteopontin in Heart Failure

A Miller School of Medicine researcher has received a $1.5 million grant from the National Heart, Lung and Blood Institute to study a potential new strategy for treating an intractable form of heart failure. “Prior studies have shown that lowering the level of a protein called osteopontin can ameliorate heart failure with reduced ejection fraction,” said Lina Shehadeh, Ph.D., assistant professor of medicine.

Read more »

Miller School of Medicine Rises in NIH Research Grant Funding

The Miller School of Medicine received $120.7 million in research grants from the National Institutes of Health in Federal Fiscal Year 2017 — a $9.5 million increase over the school’s FFY 2016 total. According to the national rankings of medical schools based on data compiled by the Blue Ridge Institute for Medical Research, that total made the Miller School the No. 1 NIH-funded institution in Florida.

Read more »